Discrimination between Candida albicans and Candida dubliniensis isolated from HIV-positive patients by using commercial method in comparison with PCR assay
Language English Country United States Media print
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
15530017
DOI
10.1007/bf02931613
Knihovny.cz E-resources
- MeSH
- Candida albicans growth & development isolation & purification MeSH
- Candida growth & development isolation & purification MeSH
- HIV Seropositivity microbiology MeSH
- Culture Media MeSH
- Humans MeSH
- Polymerase Chain Reaction methods MeSH
- Spores, Fungal physiology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Names of Substances
- Culture Media MeSH
Nineteen clinical isolates of Candida albicans and C. dubliniensis were isolated from patients (majority of them HIV-positive) in Slovakia, Brazil, Thailand and Japan. Species discrimination was performed by using growth on CHROMagar Candida, commercial biochemical set API 20C AUX, germ-tube test in human serum, growth at 42 and 45 degrees C on Sabouraud-dextrose agar as well as on CHROMagar Candida, assimilation of D-xylose and methyl alpha-D-glucoside by glass-tube test, and production of chlamydospores. These tests were completed by PCR using Cd-oligo2/F and Cd-oligo2/R primer pair specific for C. dubliniensis. Six clinical isolates were confirmed to be C. dubliniensis, remaining 13 strains were determined as C. albicans. The use of conventional method showed that the determination is markedly influenced by personal evaluation suggesting the necessity of using the combination of many tests to obtain correct results comparing with accurate and rapid PCR assay. For discrimination between C. albicans and C. dubliniensis we recommend the combination of primo-cultivation on CHROMagar, followed by germ-tube test and PCR.
See more in PubMed
J Antimicrob Chemother. 2000 Aug;46(2):291-5 PubMed
Microbiology. 1995 Jul;141 ( Pt 7):1507-21 PubMed
Oral Microbiol Immunol. 2002 Apr;17(2):89-94 PubMed
Folia Microbiol (Praha). 2002;47(2):179-81 PubMed
J Clin Microbiol. 1999 May;37(5):1587-90 PubMed
J Clin Microbiol. 2000 Aug;38(8):2829-36 PubMed
J Clin Microbiol. 2000 Jun;38(6):2423-6 PubMed
Appl Environ Microbiol. 2002 Jul;68(7):3622-7 PubMed
J Clin Microbiol. 2001 May;39(5):2015-6 PubMed
Antimicrob Agents Chemother. 2002 Jun;46(6):1695-703 PubMed
Eur J Clin Microbiol Infect Dis. 1997 Apr;16(4):296-300 PubMed
J Clin Microbiol. 1999 Nov;37(11):3533-9 PubMed
J Clin Microbiol. 1999 Dec;37(12 ):3804-8 PubMed
AIDS. 1997 Apr;11(5):557-67 PubMed
Res Microbiol. 2000 Dec;151(10):889-91 PubMed
J Mol Med (Berl). 2000;78(9):521-9 PubMed
J Clin Microbiol. 2002 Sep;40(9):3135-9 PubMed
J Clin Microbiol. 1998 Jul;36(7):2093-5 PubMed
J Clin Microbiol. 2003 May;41(5):1907-11 PubMed
Diagn Microbiol Infect Dis. 2002 Mar;42(3):181-5 PubMed
Antimicrob Agents Chemother. 2001 Dec;45(12):3416-21 PubMed
J Clin Microbiol. 2003 Jan;41(1):414-20 PubMed
J Clin Microbiol. 2003 Jan;41(1):489-91 PubMed
Folia Microbiol (Praha). 2003;48(2):233-8 PubMed
Folia Microbiol (Praha). 2001;46(5):453-7 PubMed
J Clin Microbiol. 1996 Feb;34(2):454-6 PubMed
J Clin Microbiol. 1998 Oct;36(10):3007-12 PubMed
Int J Syst Evol Microbiol. 2003 Jan;53(Pt 1):367-72 PubMed
J Clin Microbiol. 1998 Feb;36(2):329-34 PubMed
J Clin Microbiol. 1994 Aug;32(8):1923-9 PubMed
J Med Microbiol. 2002 Mar;51(3):221-4 PubMed
Methods of Candida dubliniensis identification and its occurrence in human clinical material
